Co-amilozide
| Combination of | |
|---|---|
| Amiloride | Potassium-sparing diuretic |
| Hydrochlorothiazide | Thiazide diuretic |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration |
Oral |
| ATC code | |
| Legal status | |
| Legal status |
|
| Identifiers | |
| PubChem CID | |
| ChemSpider | |
Co-amilozide (BAN) is a non- combination of amiloride and hydrochlorothiazide. Co-amilozide is used in the treatment of hypertension and congestive heart failure with the tendency of the thiazide to cause low potassium levels (hypokalaemia) offset by the potassium-sparing effects of amiloride.
Two strengths of co-amilozide are currently available in the UK:
In North America:
The most common side effect is headache (about 8% of people taking it) and nausea, loss of appetite, weakness, rash and dizziness (each about 3%).
Common side effects (1/10 - 1/100) include:
...
Wikipedia